Emailwire Feed emailwire JavaScript emailwire XML
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical....more

5-HT1 Antagonist -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “5-HT1 Antagonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1 Antagonist development. The report provides detailed coverage of the pipeline...more

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ίHSD1) Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ίHSD1) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “11 Beta-Hydroxysteroid Dehydrogenase...more

4-1BB receptor Agonist -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “4-1BB receptor Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “4-1BB receptor Agonist development. The report provides detailed coverage...more

30S Ribosomal Subunit (30S RNA) Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “30S Ribosomal Subunit (30S RNA) Inhibitor development....more

20s Proteasome Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “20s Proteasome Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “20s Proteasome Inhibitor development. The report provides detailed coverage...more

5-HT1 Agonist -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “5-HT1 Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1 Agonist development. The report provides detailed coverage of the pipeline...more

1,3-Beta-Glucan Synthase Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “1,3-Beta-Glucan Synthase Inhibitor development. The report...more

11 Beta-Hydroxysteroid Dehydrogenase (11ίHSD) Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) “11 Beta-Hydroxysteroid Dehydrogenase (11ίHSD) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “11 Beta-Hydroxysteroid Dehydrogenase (11ίHSD)...more

50S Ribosomal Subunit (50S RNA) Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) 50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “50S Ribosomal Subunit (50S RNA) Inhibitor development....more

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2027

(EMAILWIRE.COM, April 17, 2018 ) Research Cosmos's "Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Acute Myeloid Leukemia (AML) epidemiology and market outlook for the 7MM. Markets Covered United States EU5...more

Acute Myeloid Leukemia (AML) -Epidemiology Forecast to 2027

(EMAILWIRE.COM, April 17, 2018 ) Research Cosmos's "Acute Myeloid Leukemia (AML) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Acute Myeloid Leukemia (AML) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets...more

Acute Respiratory Distress Syndrome- Epidemiology Forecast to 2027

(EMAILWIRE.COM, April 17, 2018 ) Research Cosmos's "Acute Respiratory Distress Syndrome - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Acute Respiratory Distress Syndrome epidemiology, providing the historical and forecasted data for the 7MM during the forecast period...more

Acute Respiratory Distress Syndrome - Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) "Acute Respiratory Distress Syndrome - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acute Respiratory Distress Syndrome development. The report...more

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2018

(EMAILWIRE.COM, April 17, 2018 ) "Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acute Renal Failure (ARF) (Acute Kidney Injury)...more

Acute Renal Failure (ARF) (Acute Kidney Injury) - Epidemiology Forecast to 2027

(EMAILWIRE.COM, April 17, 2018 ) Research Cosmos's "Acute Renal Failure (ARF) (Acute Kidney Injury) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Acute Renal Failure (ARF) (Acute Kidney Injury) epidemiology, providing the historical and forecasted data for the 7MM...more

Pages: << < [87] 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 > >>